Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$22.17 - $51.8 $29.5 Million - $68.9 Million
-1,330,410 Reduced 32.88%
2,715,554 $140 Million
Q2 2022

Aug 15, 2022

BUY
$15.36 - $27.51 $6.21 Million - $11.1 Million
404,301 Added 11.1%
4,045,964 $100 Million
Q1 2022

May 16, 2022

BUY
$22.22 - $39.12 $21.7 Million - $38.2 Million
975,456 Added 36.59%
3,641,663 $91.3 Million
Q4 2021

Feb 14, 2022

SELL
$18.38 - $40.5 $35.1 Million - $77.3 Million
-1,908,055 Reduced 41.71%
2,666,207 $97.1 Million
Q3 2021

Nov 15, 2021

SELL
$13.18 - $19.83 $1.97 Million - $2.96 Million
-149,364 Reduced 3.16%
4,574,262 $78.2 Million
Q2 2021

Aug 16, 2021

BUY
$9.59 - $50.88 $28 Million - $148 Million
2,917,258 Added 161.5%
4,723,626 $63.2 Million
Q1 2021

May 17, 2021

SELL
$49.53 - $68.4 $10.2 Million - $14.1 Million
-206,396 Reduced 10.25%
1,806,368 $92.6 Million
Q4 2020

Feb 16, 2021

BUY
$47.25 - $65.16 $2.06 Million - $2.84 Million
43,529 Added 2.21%
2,012,764 $125 Million
Q3 2020

Nov 10, 2020

BUY
$46.35 - $61.69 $11.6 Million - $15.4 Million
249,604 Added 14.51%
1,969,235 $108 Million
Q2 2020

Aug 14, 2020

BUY
$38.58 - $65.07 $24.8 Million - $41.9 Million
643,435 Added 59.79%
1,719,631 $98.9 Million
Q1 2020

May 11, 2020

BUY
$32.73 - $50.78 $35.2 Million - $54.6 Million
1,076,196 New
1,076,196 $43.2 Million

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.